Endocrinology (all articles)
AHA Statement | Addressing diabetes and atherosclerosis in Asian American adults: insights, management, future steps
22 May, 2023 | 13:42h | UTCNews Release: Culture, diet, economic factors and more affect CVD risk among Asian Americans – American Heart Association
Commentary: Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says – TCTMD
Commentary on Twitter
Examining Asian American subgroups separately is crucial to understanding different mechanisms that contribute to T2D & ASCVD risks. The new scientific statement: https://t.co/taTVvXtXd2 @CircAHA @kwancardio @SallySWong @alka_kanaya @HeartDocSadiya @SvatiShah @FFR81 @hayman_ll pic.twitter.com/lWtl1AKBKg
— AHA Science (@AHAScience) May 8, 2023
Underdiagnosis of primary aldosteronism: a review of screening and detection
22 May, 2023 | 13:40h | UTC
Commentary on Twitter
Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection https://t.co/PYzSCZD2L7 (FREE)@MarioFunesMD @BhallaResearch @StanfordNeph pic.twitter.com/k7intLqpK3
— AJKD (@AJKDonline) May 19, 2023
RCT | Once-weekly insulin icodec shows non-inferiority to daily insulin glargine in type 2 diabetes patients
18 May, 2023 | 13:48h | UTCSwitching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
WHO advises not to use non-sugar sweeteners for weight control in newly released guideline
16 May, 2023 | 15:04h | UTCNews Release: WHO advises not to use non-sugar sweeteners for weight control in newly released guideline – World Health Organization
WHO Guideline: Use of non-sugar sweeteners – World Health Organization
Meta-Analysis: Health effects of the use of non-sugar sweeteners – World Health Organization
Canadian Task Force advises fragility fracture screening for women over 65, but not for men or younger women
15 May, 2023 | 13:23h | UTCRelated USPSTF Statement: Screening Osteoporosis to Prevent Fractures
RCT | Statins do not prevent early cardiac dysfunction in anthracycline-treated cancer patients
15 May, 2023 | 13:07h | UTCStatins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines – European Heart Journal – Cardiovascular Pharmacotherapy (link to abstract – $ for full-text)
Commentary on Twitter
Primary prevention with atorvastatin during anthracycline therapy did not prevent cardiac dysfunction and myocardial tissue changes: SPARE-HF randomized trial https://t.co/9s2p9JSSq4 #echofirst #HF #LVEF #CMR #ESCYoung #EHJPharmacotherapy @FeliceGragnano @AgewallStefan pic.twitter.com/7tKG4tdpcD
— European Society of Cardiology Journals (@ESC_Journals) May 13, 2023
M-A | Adding exercise to hypocaloric diet doesn’t enhance weight loss or glycemic control in T2D patients
15 May, 2023 | 12:52h | UTC
Endocrinopathies from checkpoint inhibitors: incidence, outcomes, and management
12 May, 2023 | 13:36h | UTCRelated:
Aspirin for primary prevention of cardiovascular disease: what do the current USPSTF guidelines say?
11 May, 2023 | 12:11h | UTCOriginal Guideline: USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.
Related Randomized Trials:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Related Meta-Analysis:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Related Opinions:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
#347 USPSTF Update: Aspirin for Primary Prevention of CVD – The Curbsiders
Review | Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
11 May, 2023 | 11:54h | UTCRelated:
Guideline Summary: New guidance on the perioperative management of diabetes.
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
FDA warns of use of selective androgen receptor modulators (SARMs) among teens, young adults
10 May, 2023 | 16:00h | UTCCommentaries:
FDA issues warning for bodybuilding products marketed to teens, young adults – AAP News
Young Men Are Using Banned ‘SARM’ Supplements to Bulk Up, With Harmful Results – HealthDay
Guideline | Use of basal insulin in the management of adults with type 2 diabetes
10 May, 2023 | 15:30h | UTCRelated: Guideline | ADA 2023 Standards of Medical Care in Diabetes.
Consensus Statement | Comprehensive type 2 diabetes management algorithm – 2023 update
9 May, 2023 | 15:10h | UTCRelated: Guideline | ADA 2023 Standards of Medical Care in Diabetes
Consensus | Addressing stigma/bias in diagnosing, managing obesity-based chronic disease, and evaluating determinants of severity
9 May, 2023 | 15:08h | UTC
RCT | Early treatment of gestational diabetes slightly lowers risk of adverse neonatal outcomes
9 May, 2023 | 14:55h | UTCTreatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Early treatment of gestational diabetes for those at higher risk beneficial, study finds – Western Sidney University
Review | Syndrome of inappropriate antidiuresis: from pathophysiology to management
9 May, 2023 | 14:37h | UTCSyndrome of Inappropriate Antidiuresis: From Pathophysiology to Management – Endocrine Reviews
Metformin: update on mechanisms of action and repurposing potential
8 May, 2023 | 13:05h | UTCMetformin: update on mechanisms of action and repurposing potential – Nature Reviews Endocrinology (if the link is paywalled, try this one in PMC)
Commentary on Twitter
New content online: Metformin: update on mechanisms of action and repurposing potential https://t.co/30uhafcKPu pic.twitter.com/kfyzDEUlBg
— Nature Reviews Endocrinology (@NatureRevEndo) May 2, 2023
Evidence-based recommendations for the dietary management of diabetes
8 May, 2023 | 12:56h | UTCEvidence-based European recommendations for the dietary management of diabetes – Diabetologia (if the link is paywalled, try this one)
Consensus Statement | Homozygous Familial Hypercholesterolemia: new treatments and clinical guidance
5 May, 2023 | 14:58h | UTC
Cohort Study | Comparison of propylthiouracil vs. methimazole for thyroid storm in critically ill patients
4 May, 2023 | 13:47h | UTCNews Release: Study: No significant differences in mortality, adverse events in patients taking thyroid medications – Boston University
SR | In people with prediabetes, Vitamin D may have a small benefit in decreasing the risk of diabetes
4 May, 2023 | 13:28h | UTCVitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
How Helpful Is Vitamin D in Prediabetes? – ConscienHealth
RCT | Best endovascular treatment first strategy yields better outcomes for chronic limb ischemia vs. vein bypass first strategy
3 May, 2023 | 15:39h | UTCCommentary: BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease – TCTMD
M-A | Efficacy of osteoporosis interventions on fracture prevention in postmenopausal women
3 May, 2023 | 15:37h | UTC
Cohort Study | Beverage consumption and mortality among adults with type 2 diabetes
26 Apr, 2023 | 14:09h | UTCEditorial: Beverages and health outcomes in adults with type 2 diabetes – The BMJ
Commentary: Healthy Beverage Choices May Lower Mortality Risk in Adults with Diabetes – HCP Live
Brief Review | Diagnosis and management of adrenal insufficiency
25 Apr, 2023 | 14:18h | UTCDiagnosis and management of adrenal insufficiency – Clinical Medicine Journal